# Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence

> **NCT02202499** · EARLY_PHASE1 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 86 (actual)

## Conditions studied

- Smoking Cessation
- Tobacco Dependence

## Interventions

- **DRUG:** Varenicline
- **OTHER:** Counseling and Support Materials
- **OTHER:** Laboratory Assessments

## Key facts

- **NCT ID:** NCT02202499
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-17
- **Primary completion:** 2015-12-11
- **Final completion:** 2019-06-14
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2020-11-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02202499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02202499, "Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02202499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*